Amino Technologies plc ("Amino"; LSE AIM: AMO), the Cambridge-based leader in digital entertainment solutions for in-home multimedia distribution, is pleased to announce that it has appointed Martin Wilks as Director of Engineering.

Amino Technologies Plc logo Amino Technologies Plc (LON: amo)'s stock had its "buy" rating reiterated by equities research analysts at Northland Capital Partners in a research note issued to investors on Wednesday, Analyst Ratings.

This new Company will initially exploit Vectura's Clickhaler� and Duohaler� dry powder inhaler (DPI) technology platforms to address current unmet needs in the Asian asthma and chronic obstructive pulmonary disease (COPD) markets.

Amino Technologies Plc (LON: amo) had its buy rating reissued by analysts at Northland Capital Partners. The firm currently has a GBX 90 ($1.39) target price on the stock.

The LNA Drug Platform overcomes the limitations of earlier antisense and siRNA technologies to deliver potent single-stranded LNA-based drug candidates across a multitude of disease states.